Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
9.04
-0.52 (-5.44%)
Mar 31, 2025, 1:43 PM EDT - Market open

Entrada Therapeutics Statistics

Total Valuation

TRDA has a market cap or net worth of $322.06 million. The enterprise value is -$20.20 million.

Market Cap 322.06M
Enterprise Value -20.20M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, before market open.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

TRDA has 35.63 million shares outstanding. The number of shares has increased by 18.01% in one year.

Current Share Class 35.63M
Shares Outstanding 35.63M
Shares Change (YoY) +18.01%
Shares Change (QoQ) +5.96%
Owned by Insiders (%) 1.04%
Owned by Institutions (%) 52.93%
Float 19.03M

Valuation Ratios

The trailing PE ratio is 5.38.

PE Ratio 5.38
Forward PE n/a
PS Ratio 1.69
Forward PS 7.62
PB Ratio 0.79
P/TBV Ratio 0.79
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.15, with a Debt / Equity ratio of 0.14.

Current Ratio 11.15
Quick Ratio 10.78
Debt / Equity 0.14
Debt / EBITDA 0.92
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 19.56% and return on invested capital (ROIC) is 7.36%.

Return on Equity (ROE) 19.56%
Return on Assets (ROA) 5.90%
Return on Invested Capital (ROIC) 7.36%
Return on Capital Employed (ROCE) 9.66%
Revenue Per Employee $1.15M
Profits Per Employee $358,612
Employee Count 183
Asset Turnover 0.42
Inventory Turnover n/a

Taxes

In the past 12 months, TRDA has paid $859,000 in taxes.

Income Tax 859,000
Effective Tax Rate 1.29%

Stock Price Statistics

The stock price has decreased by -35.99% in the last 52 weeks. The beta is 0.02, so TRDA's price volatility has been lower than the market average.

Beta (5Y) 0.02
52-Week Price Change -35.99%
50-Day Moving Average 11.90
200-Day Moving Average 15.47
Relative Strength Index (RSI) 26.72
Average Volume (20 Days) 87,561

Short Selling Information

The latest short interest is 1.23 million, so 3.46% of the outstanding shares have been sold short.

Short Interest 1.23M
Short Previous Month 1.38M
Short % of Shares Out 3.46%
Short % of Float 6.48%
Short Ratio (days to cover) 9.77

Income Statement

In the last 12 months, TRDA had revenue of $210.78 million and earned $65.63 million in profits. Earnings per share was $1.68.

Revenue 210.78M
Gross Profit 85.48M
Operating Income 47.01M
Pretax Income 40.51M
Net Income 65.63M
EBITDA 50.78M
EBIT 47.01M
Earnings Per Share (EPS) $1.68
Full Income Statement

Balance Sheet

The company has $420.00 million in cash and $59.21 million in debt, giving a net cash position of $360.79 million or $10.13 per share.

Cash & Cash Equivalents 420.00M
Total Debt 59.21M
Net Cash 360.79M
Net Cash Per Share $10.13
Equity (Book Value) 428.68M
Book Value Per Share 12.04
Working Capital 400.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.56 million and capital expenditures -$3.16 million, giving a free cash flow of -$44.72 million.

Operating Cash Flow -41.56M
Capital Expenditures -3.16M
Free Cash Flow -44.72M
FCF Per Share -$1.26
Full Cash Flow Statement

Margins

Gross margin is 40.55%, with operating and profit margins of 22.30% and 31.13%.

Gross Margin 40.55%
Operating Margin 22.30%
Pretax Margin 31.54%
Profit Margin 31.13%
EBITDA Margin 24.09%
EBIT Margin 22.30%
FCF Margin n/a

Dividends & Yields

TRDA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.01%
Shareholder Yield n/a
Earnings Yield 19.27%
FCF Yield -13.13%

Analyst Forecast

The average price target for TRDA is $25.67, which is 183.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target $25.67
Price Target Difference 183.96%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) -34.72%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TRDA has an Altman Z-Score of 4.53 and a Piotroski F-Score of 5.

Altman Z-Score 4.53
Piotroski F-Score 5